| Product Name | MF | CAS | Details |
|---|
| 8-Benzyloxy-5-(2-Bromoacetyl)-2-Hydroxyquinoline | C18H14BrNO3 | 100331-89-3 | Details |
| 3,5-Dimethoxyaniline | C8H11NO2 | 10272-07-8 | Details |
| (3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide | C19H17F2N3O5 | 1051375-10-0 | Details |
| Cabotegravir Sodium | C19H18F2N3NaO5 | 1051375-13-3 | Details |
| Dolutegravir | C20H19F2N3O5 | 1051375-16-6 | Details |
| Dolutegravir sodium salt | C20H20F2N3NaO5 | 1051375-19-9 | Details |
| GSK1120212 (DMSO solvate) | C28H29FIN5O5S | 1187431-43-1 | Details |
| n-(3-(5-(2-amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide | C23H20F3N5O2S2 | 1195765-45-7 | Details |
| dabrafenib mesylate | C24H24F3N5O5S3 | 1195768-06-9 | Details |
| methyl 3-amino-2-fluorobenzoate | C8H8FNO2 | 1195768-18-3 | Details |
| Methyl 3-(2,6-difluorophenylsulfonamido)-2-fluorobenzoate | C14H10F3NO4S | 1195768-19-4 | Details |
| 2H-Cyclopenta[b]furan-2,5-diol, hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- | C18H21F3O5 | 1204185-88-5 | Details |
| 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one | C16H12Cl2O | 124379-29-9 | Details |
| dimethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5-dicarboxylate | C16H14O7 | 1246616-66-9 | Details |
| 1-(2,2-Dimethoxyethyl)-1,4-dihydro-3-methoxy-4-oxo-2,5-pyridinedicarboxylic acid 2-methyl ester | C13H17NO8 | 1335210-23-5 | Details |
| (3S,11aR)-N-[(2,4-difluorophenyl)methyl]-3-methyl-6-(methyloxy)-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide | C13H14N2O6 | 1335210-24-6 | Details |
| (4R,12aS)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid | C14H16N2O6 | 1335210-34-8 | Details |
| (4r,12as)-n-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2h-pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide | C21H21F2N3O5 | 1335210-35-9 | Details |
| Dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate | C20H23NO8 | 1357289-08-7 | Details |
| (1R,2R)-1-amino-2-(difluoromethyl)-N-((1-methylcyclopropyl)sulfonyl)cyclopropane-1-carboxamide | C9H14F2N2O3S | 1360997-58-5 | Details |
| Glecaprevir | C38H46F4N6O9S | 1365970-03-1 | Details |
| 136790-72-2 | C20H28F2O5 | 136790-72-2 | Details |
| Latanoprost Lactone Diol | C18H24O4 | 145667-75-0 | Details |
| benzyl 2-bromoethyl ether | C9H11BrO | 1462-37-9 | Details |
| Cyclopropanesulfonamide | C3H7NO2S | 154350-29-5 | Details |
| Bimatoprost | C25H37NO4 | 155206-00-1 | Details |
| 4-(methylthio)phenylacetic acid | C9H10O2S | 16188-55-9 | Details |
| Celecoxib | C17H14F3N3O2S | 169590-42-5 | Details |
| 5-(2R)-2-Oxiranyl-8-benzyloxy-2(1H)-quinolinone | C18H15NO3 | 173140-90-4 | Details |
| 1-(3,4-DIMETHYLPHENYL)-3-METHYL-3-PYRAZOLIN-5-ONE | C12H14N2O | 18048-64-1 | Details |
| 2-mercapto-N-methylbenzamide | C8H9NOS | 20054-45-9 | Details |
| Etoricoxib | C18H15ClN2O2S | 202409-33-4 | Details |
| cyclopropanecarbothioamide | C4H7NS | 20295-34-5 | Details |
| Tafluprost | C25H34F2O5 | 209860-87-7 | Details |
| tafluprost acid | C22H28F2O5 | 209860-88-8 | Details |
| 2H-Cyclopenta[b]furan-2-one,5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-,(3aR,4R,5R,6aS)- | C24H22F2O5 | 209861-00-7 | Details |
| (3aR,4R,5R,6aS)-4-((E)-3,3-Difluoro-4-phenoxybut-1-en-1-yl)-5-hydroxyhexahydro-2H-cyclopenta[b]furan-2-one | C17H18F2O4 | 209861-01-8 | Details |
| TF-Diol | C17H20F2O4 | 209861-02-9 | Details |
| 1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone | C15H15NOS | 221615-72-1 | Details |
| 2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)-ETHAN-1-ONE | C15H15NO3S | 221615-75-4 | Details |
| Ethyl quinuclidine-4-carboxylate hydrochloride | C10H18ClNO2 | 22766-67-2 | Details |
| 1-Azabicyclo[2.2.2]octane-4-carboxylic acid ethyl ester | C10H17NO2 | 22766-68-3 | Details |
| dimethyl trithiocarbonate | C3H6S3 | 2314-48-9 | Details |
| 2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate | C7H14ClF6N2P | 249561-98-6 | Details |
| 2,2'-dithiobis[N-methylbenzamide] | C16H16N2O2S2 | 2527-58-4 | Details |
| 6-Iodo-1H-indazole | C7H5IN2 | 261953-36-0 | Details |
| 2-(3,4-Dimethylphenyl)-1,2-dihydro-5-methyl-3H-pyrazol-3-one | C12H14N2O | 277299-70-4 | Details |
| 5,6-Diethyl-2,3-dihydro-1H-inden-2-amine hydrochloride | C13H20ClN | 312753-53-0 | Details |
| Axitinib | C22H18N4OS | 319460-85-0 | Details |
| Dimethyl (2-oxoheptyl)phosphonate | C9H19O4P | 36969-89-8 | Details |
| 2-Hydroxy-3''-Nitro-Biphenyl-3-Carboxylic Acid | C13H9NO5 | 376591-95-6 | Details |
| 3'-aMino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid hydrochloride | C13H12ClNO3 | 376591-97-8 | Details |
| [1,1'-Biphenyl]-3-carboxylic acid, 5'-chloro-2'-hydroxy- | C13H9ClO3 | 376592-57-3 | Details |
| 5'-Chloro-2'-hydoxy-3'-nitro-(1,1'-biphenyl)-3-Carboxylic acid | C13H8ClNO5 | 376592-58-4 | Details |
| [1,1'-Biphenyl]-3-carboxylicacid, 3'-amino-2'-hydroxy- | C13H11NO3 | 376592-93-7 | Details |
| (Z)-7-[(1R,2R,3R,5S)-3,5-DIHYDROXY-2-((E)-(S)-3-HYDROXY-5-PHENYL-PENT-1-ENYL)-CYCLOPENTYL]-HEPT-5-ENOIC ACID METHYL ESTER | C24H34O5 | 38315-47-8 | Details |
| 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA | C23H32O5 | 38344-08-0 | Details |
| 4-Chloro-6-fluoroquinoline | C9H5ClFN | 391-77-5 | Details |
| 6-Fluoro-4-hydroxyquinoline | C9H6FNO | 391-78-6 | Details |
| Dimethyl(3-phenoxy-2-oxopropyl)phosphonate | C11H15O5P | 40665-68-7 | Details |
| Dimethyl-(2-oxo-4-phenylbutyl)phosphonate | C12H17O4P | 41162-19-0 | Details |
| BP-2 (LT-EDI) | C18H22O4 | 41639-74-1 | Details |
| Pazopanib | C21H23N7O2S | 444731-52-6 | Details |
| 2,3-Dimethyl-6-Amino-2H-Indazole | C9H11N3 | 444731-72-0 | Details |
| 2,3-dimethyl-6-nitro-2H-indazole | C9H9N3O2 | 444731-73-1 | Details |
| N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine | C13H12ClN5 | 444731-74-2 | Details |
| N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine | C14H14ClN5 | 444731-75-3 | Details |
| (5R)-2-Oxazolidinone, 5-(2,2-diMethyl-4H-1,3-benzodioxin-6-yl) | C13H15NO4 | 452339-73-0 | Details |
| Eltrombopag | C25H22N4O4 | 496775-61-2 | Details |
| Eltrombopag Olamine | C27H29N5O5 | 496775-62-3 | Details |
| 2-(2-(6-bromohexyloxy)ethoxymethyl)-1,3-dichlorobenzene | C15H21BrCl2O2 | 503070-57-3 | Details |
| Vilanterol trifenatate | C44H49Cl2NO7 | 503070-58-4 | Details |
| 8-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]quinolin-2(1H)-one | C18H16BrNO3 | 530084-79-8 | Details |
| TP-2 (TV-EDI) (Travoprost) | C18H19F3O5 | 53872-60-9 | Details |
| Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate | C12H14F3O5P | 54094-19-8 | Details |
| TV-BPK (Travoprost) | C31H25F3O6 | 54142-64-2 | Details |
| methyl 6-methylnicotinate | C8H9NO2 | 5470-70-2 | Details |
| 2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-, (3aR,4R,5R,6aS)- | C25H26O5 | 55444-68-3 | Details |
| 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine | C7H13N3 | 5807-14-7 | Details |
| 2,2,2-Trimethylthioacetamide | C5H11NS | 630-22-8 | Details |
| CYCLOPROPANESULFONIC ACID TERT-BUTYLAMIDE | C7H15NO2S | 630421-42-0 | Details |
| N-tert-Butyl-3-chloropropane-1-sulfonamide | C7H16ClNO2S | 63132-85-4 | Details |
| 2,3-dimethylindazol-6-amine hydrochloride | C9H12ClN3 | 635702-60-2 | Details |
| Pazopanib Hydrochloride | C21H24ClN7O2S | 635702-64-6 | Details |
| 1-Methylcyclopropane-1-sulfonamide | C4H9NO2S | 669008-26-8 | Details |
| 3-Iodo-6-nitroindazole | C7H4IN3O2 | 70315-70-7 | Details |
| (R)-5-[2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one Maleate | C28H32N2O7 | 753498-25-8 | Details |
| 1,3,4,6,7,8-HEXAHYDRO-1-METHYL-2H-PYRIMIDOL[1,2-A]PYRIMIDINE | C8H15N3 | 84030-20-6 | Details |
| Umeclidinium bromide | C29H34BrNO2 | 869113-09-7 | Details |
| N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide | C26H23FIN5O4 | 871700-17-3 | Details |
| 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6-(methylamino)pyrimidine-2,4(1H,3H)-dione | C14H13FIN3O2 | 871700-22-0 | Details |
| 3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-diMethylpyrido[2,3-d]pyriMidine-2,4,7(1H,3H,8H)-trione | C18H15FIN3O4 | 871700-24-2 | Details |
| N-(3-(3-cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-diMethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyriMidin-5-ylaMino)phenyl)acetaMide | C26H23FIN5O4 | 871700-25-3 | Details |
| 6-aMino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyriMidine-2,4(1H,3H)-dione | C13H11FIN3O2 | 871700-28-6 | Details |
| Benzenamine, 2,6-dichloro-3,5-dimethoxy- | C8H9Cl2NO2 | 872509-56-3 | Details |
| (E)-6-iodo-3-(2-(pyridin-2-yl)vinyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole | C19H18IN3O | 886230-77-9 | Details |
| Hydroxyethyl Starch | (C6H10O5)m(C2H5O)n | 9005-27-0 | Details |
| 4-(Methylsulfonyl)phenylacetic acid | C9H10O4S | 90536-66-6 | Details |
| Axitinib Impurity B | C15H13N3OS | 944835-85-2 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||